Podoverine C



Compound IDCDAMM02625
Common namePodoverine C
IUPAC name3-[4-(5,7-dihydroxy-3-methoxy-4-oxochromen-2-yl)-2-hydroxy-3-(3-methylbut-2-enyl)phenoxy]-2,3,5,7-tetrahydroxy-2-(4-hydroxyphenyl)chromen-4-one
Molecular formulaC36H30O14

Experimental data

Retention time7.63
Adduct[M+H]+
Actual mz687.179
Theoretical mz687.171
Error11.39
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.0597

Identifiers and class information

Inchi keyJTYQTVPZTBVCSU-UHFFFAOYNA-N
SmilesO=C1C(OC)=C(OC=2C=C(O)C=C(O)C12)C=3C=CC(OC4(O)C(=O)C=5C(O)=CC(O)=CC5OC4(O)C6=CC=C(O)C=C6)=C(O)C3CC=C(C)C
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)7
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)686.625
Computed dipole moment(dipole)6.262
Total solvent accessible surface area (SASA)949.72
Hydrophobic component of SASA (FOSA)240.338
Hydrophilic component of SASA (FISA)385.399
Pie component of the SASA (PISA)323.982
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1838.47
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)10.75
Free energy of solvation of dipole (dip^2/V)0.0213318
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0277261
Globularity descriptor (glob)0.764199
Predicted polarizability in cubic angstroms (QPpolrz)62.168
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.819
Predicted octanol/gas partition coefficient (QPlogPoct)36.829
Predicted water/gas partition coefficient (QPlogPw)23.339
Predicted octanol/water partition coefficient (QPlogPo/w)3.197
Predicted aqueous solubility (QPlogS)-6.831
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.161
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.893
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)2.194
Predicted brain/blood partition coefficient (QPlogBB)-4.62
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.661
Predicted skin permeability, log Kp (QPlogKp)-6.233
PM3 calculated ionization potential (IP(ev))8.883
PM3 calculated electron affinity (EA(eV))0.616
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)0.621
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)12.892
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)233.906
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)3

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
P14679TYRTyrosinaseT97035SEA
Q9NPH5NOX4NADPH oxidase 4T29741SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
Q04760GLO1Glyoxalase IT88285SEA
Q9HC98NEK6Serine/threonine-protein kinase NEK6T78992SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q15717ELAVL1ELAV-like protein 1T78349SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T29741DI0146Fibrosis[ICD-11: GA14-GC01]Q9NPH5NOX4
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS

Copyright © 2025